10
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T60014 | SHEN26 | Antiviral | |
SHEN26 has antiviral activity and can be used in research on the treatment of viral infections. | |||
T60540 | Netivudine | ||
Netivudine is a potent nucleoside reverse transcriptase inhibitor (NRTIs), a nucleoside analogue with anti-varicella zoster virus activity that can be used to treat human immunodeficiency virus (HIV) infection. Netivudin... | |||
T61824 | NIOCH 14 | ||
NIOCH 14 is an antiviral agent and pro-drug with demonstrated potency against orthopoxviruses. It exhibits significant efficacy in reducing infection rates and lung viral load in mice. NIOCH 14 is particularly useful for... | |||
T76847 | Imdevimab | ||
Imdevimab (REGN10987), a human monoclonal antibody designed to neutralize the SARS-CoV-2 virus responsible for COVID-19, demonstrates reduced efficacy against emerging COVID-19 variants. When combined with Casirivimab, i... | |||
T76846 | Casirivimab | ||
Casirivimab (REGN10933), a human monoclonal antibody targeting the SARS-CoV-2 virus responsible for COVID-19, demonstrates reduced efficacy against emerging variants. When combined with Imdevimab, it significantly lowers... | |||
T69731 | Remdesivir maleate | ||
Remdesivir, also known as GS-5734, is a prodrug form of the antiviral nucleoside analog GS-44152. Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2, in vitro and in vivo. Efficacy of re... | |||
T82937 | ATV041 | ||
ATV041, an orally active compound that combines features of Ibuprofen and nucleotide analogues, enhances the oral pharmacokinetic (PK) profile and tissue distribution, exhibiting anti-mouse hepatitis virus (MHV) activity... | |||
T76991 | Suvizumab | ||
Suvizumab (KD-247), a neutralizing antibody against HIV-1, effectively neutralizes strains HIV-1 MN, HIV-1 SF2, and HIV-1 89.6, exhibiting IC50 values of 0.1 µg/mL, 1.0 µg/mL, and 0.2 µg/mL, respectively. It demonstrates... | |||
T83707 | F9170 TFA | ||
F9170, an antiviral peptide derived from the HIV-1 envelope glycoprotein (amino acids 789-803), targets the LLP1 domain in the virus's envelope protein cytoplasmic tail. This interaction inhibits HIV-1 IIIB infection in ... | |||
T37295 | Ganglioside GM1 Asialo Mixture | ||
Ganglioside GM1 asialo is a component of cellular lipid rafts and can be formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase. Ganglioside GM1 asialo is a glycolipid receptor for P. aer... |